{"database": "lobbying", "table": "lobbying_activities", "rows": [[2102815, "3d6f99f6-df84-4205-868b-8533e3e41564", "Q1", "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 1466, "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 2018, "first_quarter", "MMM", "AACC joined with other healthcare groups in writing to the Administrator of the Centers for Medicare and Medicaid Services requesting that the agency notify state Medicaid agencies of the recent federal cuts in the clinical laboratory fee schedule (as a result of Section 216 of the Protecting Access to Medicare Act) and how additional state rate reductions in lab fees could adversely affect patient access to testing services.", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", null, 70000, 0, 0, "2018-04-09T10:00:36.437000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2102815"], "units": {}, "query_ms": 0.8731449997867458, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}